CBIO

Is a Surprise Coming for Catalyst Biosciences (CBIO) This Earnings Season?

Catalyst Biosciences Reports First Quarter 2021 Operating & Financial Results and Provides a Corporate Update

Catalyst Biosciences to Present at the 20th Annual Needham Virtual Healthcare Conference

Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update

Catalyst Biosciences Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering of Common Stock

Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress

Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress